Fundraising FoxCosmos Holdings
NASDAQ: COSMChicago, US · Nevada corporation
Find your way into Cosmos Holdings
Sign up to see every warm intro you have to Cosmos Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cosmos Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cosmos Health manufactures and distributes generic pharmaceuticals, branded nutraceuticals, and biocides through a vertically integrated global healthcare operation, while also conducting research and development of innovative drugs, drug repurposing initiatives, and operating a telehealth platform.
Founders & leadership
GS
Grigorios SiokasExecutive
JJ
John J HoidasNamed on SEC filing
DG
Demetrios G DemetriadesNamed on SEC filing
DG
Dimitrios GoulielmosNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$44.3M disclosed across 5 rounds · 2017–2023
▶$5.3MraisedJul 2023 · 3 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedJul 2023 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anastasios AslidisDirector
- Grigorios SiokasExecutive Officer, Director
- John J. HoidasDirector
- Manfred ZieglerDirector
- Demetrios G. DemetriadesDirector
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- Minimum investment
- $100K
- Sales commissions
- $310.4K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Jul 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$32.5MraisedJan 2023 · PharmaceuticalsRule 506(b)
▶$32.5MraisedJan 2023 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anastasios AslidisDirector
- Demetrios G. DemetriadesDirector
- Grigorios SiokasExecutive Officer, Director
- Manfred ZieglerDirector
- John J. HoidasDirector
- Offering amount
- $32.5M
- Amount sold
- $32.5M
- Minimum investment
- $100K
- Sales commissions
- $1.6M
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Dec 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.5MraisedJun 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J HoidasDirector
- Demetrios G DemetriadesDirector
- Dimitrios GoulielmosDirector
- Grigorios SiokasExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- Sales commissions
- $90K
- Placement agents
- Roth Capital Partners LLC
- First sale
- May 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2MraisedSep 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedSep 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Grigorios SiokasExecutive Officer, Director
- Dimitrios GoulielmosDirector
- Demetrios G DemetriadesDirector
- John J HoidasDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $500K
- Sales commissions
- $140K
- Placement agents
- Roth Capital Partners LLC
- First sale
- Sep 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3MraisedNov 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$3MraisedNov 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J HoidasDirector
- Demetrios G DemetriadesDirector
- Dimitrios GoulielmosDirector
- Grigorios SiokasExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $500K
- Sales commissions
- $240K
- Placement agents
- Roth Capital Partners LLC
- First sale
- Nov 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cosmos Holdings do?
- Cosmos Health manufactures and distributes generic pharmaceuticals, branded nutraceuticals, and biocides through a vertically integrated global healthcare operation, while also conducting research and development of innovative drugs, drug repurposing initiatives, and operating a telehealth platform.
- How much funding has Cosmos Holdings raised?
- Cosmos Holdings has disclosed $44.3M raised across 5 rounds.
- Where is Cosmos Holdings headquartered?
- Cosmos Holdings is headquartered in Chicago, US.